Acquisitions and Intangible Assets

Acquisitions

During 2009, we acquired the remaining 31 percent interest in our Andean region subsidiary, Colombiana Kimberly Colpapel S.A. for $289 million. The acquisition was recorded as an equity transaction that reduced noncontrolling interests, accumulated other comprehensive income ("AOCI") and additional paid-in capital classified in stockholders’ equity by $278 million and increased investments in equity companies by $11 million.

During 2009, we acquired Jackson Products, Inc. (“Jackson”), a privately-held safety products company, for $155 million, net of cash acquired. The excess of the purchase price over the fair values of assets and liabilities acquired resulted in recognition of goodwill of $95 million, none of which is deductible for income tax purposes. Jackson’s net sales were 3 percent of the KCP & Other business segment net sales in 2009.

During 2009, we acquired Baylis Medical Company’s pain management business. Our Health Care business has been the exclusive distributor of these pain management products in the U.S. since 2001. The excess of the purchase price over the fair values of assets and liabilities acquired resulted in recognition of goodwill of $19 million, the majority of which is deductible for income tax purposes.

During 2009, we acquired I-Flow Corporation (“I-Flow”), a healthcare company that develops and markets drug delivery systems and products for post-surgical pain relief and surgical site care, for $262 million, net of cash acquired. The excess of the purchase price over the fair values of assets and liabilities acquired resulted in recognition of goodwill of $153 million, none of which is deductible for income tax purposes. In 2009, I-Flow’s net sales were 1 percent of the Health Care business segment net sales.

Goodwill

The changes in the carrying amount of goodwill by business segment are as follows:



	Personal Care			Consumer Tissue			K-C Professional & Other			Health Care			Total
	(Millions of dollars)
Balance at December 31, 2009	$	745		$	669		$	435		$	1,426		$	3,275
Currency and other	58			45			16			9			128
Balance at December 31, 2010	803			714			451			1,435			3,403
Currency and other	(34		)	(20		)	(8		)	(1		)	(63		)
Balance at December 31, 2011	$	769		$	694		$	443		$	1,434		$	3,340

Other Intangible Assets

At December 31, 2011 and 2010, we had intangible assets with indefinite useful lives of $11 million related to acquired in-process research and development. Intangible assets subject to amortization consist of the following at December 31:



	2011				2010
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
	(Millions of dollars)
Trademarks	$	252	$	147	$	257	$	141
Patents and developed technologies	157		53		157		48
Other	96		51		93		42
Total	$	505	$	251	$	507	$	231

Amortization expense for intangible assets was $24 million in 2011, $25 million in 2010 and $18 million in 2009. Amortization expense is estimated to be $29 million in 2012, $39 million in 2013, $40 million in 2014, $32 million in 2015 and $25 million 2016.